Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Sathish Kumar Gopalakrishnan"'
Autor:
Yunxin Chen, Sathish Kumar Gopalakrishnan, Melissa Ooi, Rehena Sultana, Li Hui Lim, Nicholas Grigoropoulos, Shin Yeu Ong, Mingge Xu, SGHMM1 Investigators, Wee Joo Chng, Yeow Tee Goh, Chandramouli Nagarajan
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 9, Pp 1-4 (2021)
Externí odkaz:
https://doaj.org/article/72e572af96154f45ac83e67105398350
Autor:
Rehena Sultana, Yunxin Chen, Sghmm Investigators, Shin Yeu Ong, Li Hui Lim, Melissa Ooi, Sathish Kumar Gopalakrishnan, Yeow Tee Goh, Wee Joo Chng, Chandramouli Nagarajan, Mingge Xu, Nicholas Grigoropoulos
Publikováno v:
Blood Cancer Journal
Blood Cancer Journal, Vol 11, Iss 9, Pp 1-4 (2021)
Blood Cancer Journal, Vol 11, Iss 9, Pp 1-4 (2021)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c20e1288dd2b5c038bb8609dfcccd87
https://doi.org/10.1038/s41408-021-00544-x
https://doi.org/10.1038/s41408-021-00544-x
Autor:
Hideki Asaoku, Hiroshi Kosugi, Jae Hoon Lee, Kihyun Kim, Jin Seok Kim, Shang-Yi Huang, Chang-Ki Min, Hideo Kimura, Wee Joo Chng, Cinnie Yentia Soekojo, Brian G.M. Durie, Naoki Takezako, Shu Ling Lee, Junichi Sakamoto, Yuan Wei, Rajesh Moorakonda, Sathish Kumar Gopalakrishnan, Chandramouli Nagarajan, Chor Sang Chim, Sung Soo Yoon, Je-Jung Lee
Publikováno v:
Blood Cancer Journal, Vol 9, Iss 10, Pp 1-10 (2019)
Blood Cancer Journal
Blood Cancer Journal
Pomalidomide is a third generation immunomodulatory drug which in combination with dexamethasone, has been shown to be active in relapsed/refractory multiple myeloma. However, the data in Asian patients remain limited. We conducted a prospective phas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77667197030621ea57bc92e22ea9be40
http://link.springer.com/article/10.1038/s41408-019-0245-1
http://link.springer.com/article/10.1038/s41408-019-0245-1
Autor:
Ayman Saad, Tamila L. Kindwall-Keller, Raphael Fraser, Sathish Kumar Gopalakrishnan, Rammurti T. Kamble, Anita D'Souza, Cesar O. Freytes, Melhem Solh, Robert A. Kyle, Hillard M. Lazarus, Jesus G. Berdeja, Siddhartha Ganguly, Robert Peter Gale, Taiga Nishihori, Parameswaran Hari, Kenneth R. Meehan, Tomer M Mark, Saad Z. Usmani, Cindy Lee, Miguel Angel Diaz, Usama Gergis, Binod Dhakal, Abraham S. Kanate, Shaji Kumar, Amer Assal, Omar Davila, Emma C. Scott, Frederick L. Locke, Yago Nieto, Cristina Gasparetto, Gerhard C. Hildebrandt, Bipin N. Savani, Nina Shah, Sachiko Seo
Publikováno v:
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
The revised International Staging System (R-ISS) combines ISS with genetic markers and lactate dehydrogenase and can prognosticate newly diagnosed multiple myeloma (MM). Early relapse (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cb136a71ce040cc301383c02d30abd3
https://doi.org/10.1016/j.bbmt.2018.12.141
https://doi.org/10.1016/j.bbmt.2018.12.141
Autor:
Mickey Koh, Aloysius Ho, Yeh Ching Linn, Jeffrey Kim Siang Quek, Yeow Tee Goh, Francesca Lorraine Wei Inng Lim, Sathish Kumar Gopalakrishnan, Jing Jing Lee, William Hwang, Yvonne Loh, Colin Phipps Diong
Publikováno v:
Transfusion. 59:335-339
Background Hemolysis at the time of graft infusion is one of the immediate complications in major ABO-incompatible allogeneic hematopoietic stem cell transplants (HSCTs). We conducted a retrospective analysis to evaluate the efficacy of donor-type fr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95d13ec0b95a52a42da9db5dc8e37487
https://doi.org/10.1111/trf.15053
https://doi.org/10.1111/trf.15053
Autor:
Daryl Tan, Yuh Shan Lee, Soon Thye Lim, Tiffany Tang, Colin Phipps, Alan Z Goh, Heng Joo Ng, Aditi Ghosh, Yunxin Chen, Yvonne Loh, Sathish Kumar Gopalakrishnan, Hao Ying, Chandramouli Nagarajan, Nicholas Francis Grigoropoulos, Yeow Tee Goh, William Hwang
Publikováno v:
Leukemia & Lymphoma. 59:2336-2341
Diffuse large B-cell lymphoma (DLBCL) is a high-grade lymphoma that requires treatment. We retrospectively analyzed the impact of time from diagnosis-to-treatment (TDT) on progression-free survival (PFS) and overall survival (OS) in 581 R-CHOP-treate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8d44209f11d4e4ac8e9a07ff9a7c378
https://doi.org/10.1080/10428194.2017.1422863
https://doi.org/10.1080/10428194.2017.1422863
Autor:
Sathish Kumar Gopalakrishnan, Jane L Chua, Yuh Shan Lee, Lawrence Ng, Colin Phipps, Yunxin Chen, Yeow Tee Goh, Chandramouli Nagarajan, Heng Joo Ng, William Yk Hwang, Melinda Si Yun Tan, Nicholas Francis Grigoropoulos, Shin Yeu Ong
Publikováno v:
Blood. 136:25-26
Introduction Patients with relapsed/ refractory (R/R) diffuse large B-cell lymphoma (DLBCL) whom are transplant-ineligible have limited treatment options. To address this specific treatment challenge, we undertook a clinical trial combining lenalidom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b70ec3e4ad3ed563cdf46889da5b7299
https://doi.org/10.1182/blood-2020-142275
https://doi.org/10.1182/blood-2020-142275
Autor:
Adeline Lin, Yunxin Chen, Li Mei Poon, Lip Kun Tan, Jin Lu, Guo-miao Wang, Chandramouli Nagarajan, Xiao-Jun Huang, Grace Wolyncewicz, Andrew Spencer, Joshua Casan, Liang Piu Koh, Melissa Ooi, Wee Joo Chng, Sathish Kumar Gopalakrishnan, Cinnie Yentia Soekojo, Yang Liu, Sanjay de Mel, Yue-Yun Lai
Publikováno v:
Clinical lymphoma, myelomaleukemia. 19(8)
Background The Revised International Staging System (R-ISS) has been widely adopted to prognosticate multiple myeloma. As a result, the continued utility of conventional metaphase karyotyping has been called into question. Patients and Methods A mult
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65e4f1269863dd20be07d924fdabdebe
https://pubmed.ncbi.nlm.nih.gov/31171473
https://pubmed.ncbi.nlm.nih.gov/31171473
Publikováno v:
Clinical nuclear medicine. 44(4)
Extramedullary multiple myeloma (EM) has negative prognostic implications on the overall survival as well as progression-free survival. Testis is a rare site of EM, which can be a part of diffuse involvement in multiple myeloma or a site of recurrenc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f39b53ee17b7571a7647d5cb0941f57
https://pubmed.ncbi.nlm.nih.gov/30688733
https://pubmed.ncbi.nlm.nih.gov/30688733
Autor:
S de Mel, Sathish Kumar Gopalakrishnan, S M Y Loh, Yunxin Chen, Shin-Yeu Ong, Melissa Ooi, Wee Joo Chng, Liang Piu Koh, Y T Goh, Adeline Lin, William Hwang, Daryl Tan, Aloysius Yl Ho, Y C Linn, Colin Phipps, Shilpa Surendran
Publikováno v:
Bone Marrow Transplantation. 51:933-937
The clinical outcome of multiple myeloma is heterogeneous. Both the depth of response to induction and transplant as well as early relapse within a year are correlated with survival, but it is unclear which factor is most relevant in Southeast Asian
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::353a84ff86c22527da994d4437d68959
https://doi.org/10.1038/bmt.2016.43
https://doi.org/10.1038/bmt.2016.43